China Retaliates Against European Union Device Manufacturers

Imposes a ban on European medical devices

Growing China-EU Trade Conflict

The medical device industry is now the latest battleground in a growing China-EU trade conflict – with potential ripple effects across global supply chains and health procurement markets.

The AP reports that in an escalating trade dispute, China has barred European medical device companies from participating in government procurement contracts over 45 million yuan ($6.28 million). The ban, announced Sunday by China’s Finance Ministry, took effect immediately and is seen as retaliation for European Union trade restrictions on Chinese products.

Key Details:

  • The ban applies only to non-Chinese-manufactured EU products.
  • EU firms that produce within China are exempt.
  • It mirrors a June EU policy excluding Chinese companies from public procurement over €5 million.

Broader EU-China Trade Tensions

  • On Friday, China imposed anti-dumping duties on European brandy, particularly affecting French cognac.
  • China is also investigating EU pork and dairy imports following EU actions targeting Chinese electric vehicles (EVs).
  • The EU claims China’s procurement process discriminates against foreign firms, citing legal and administrative barriers.

China’s Response

China’s Ministry of Commerce said it had shown goodwill and willingness to negotiate but accused the EU of ignoring diplomatic overtures and erecting new protectionist barriers.

Read more here

Abbott Safety Alert for Freestyle Libre Systems

Misuse may cause battery overheating and incorrect readings The FDA has issued a safety notification regarding the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash Glucose Monitoring Systems. The notification warns users of the potential for...

Camber Recalls Atovaquone Oral Suspension USP

Camber Recalls Atovaquone Oral Suspension USP for Potential Contamination Camber Pharmaceuticals Inc. recently issued a voluntary nationwide recall of Atovaquone Oral Suspension USP due to potential contamination. The recall was announced by the U.S. Food and Drug...

Prodigy Proclaim Spinal Cord Stimulation Systems

Significant advancement for chronic pain treatment On February 15, 2023, the U.S. Food and Drug Administration (FDA) announced the approval of the Prodigy Proclaim and Proclaim XR Spinal Cord Stimulation (SCS) systems. This approval marks a significant step forward in...